StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Brean Capital Cuts Price Target After Horizon Pharma (HZNP) Releases Soft Guidance
April 14, 2016 9:40 AM
Brean Capital maintained a Buy rating on Horizon Pharma (NASDAQ: HZNP), and cut the price target to $30.00 (from $32.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Next Articles
UBS Cuts Price Target on Horizon Pharma (HZNP) After Meeting with Management
April 13, 2016 8:20 AM
Piper Jaffray Remains Bullish on Horizon Pharma (HZNP) as Stock Loses Value
April 13, 2016 7:55 AM
Unusual 11 Mid-Day Movers 4/12: (CHK) (HPJ) (DNR) Higher; (HZNP) (OZM) (TTOO) Lower
April 12, 2016 1:02 PM
Horizon Pharma (HZNP) OTM Calls Active Despite Massive Sell-Off
April 12, 2016 1:00 PM
Pre-Open Stock Movers 04/12: (FOLD) (ARNA) (HLX) Higher; (HZNP) (OZM) (JNPR) Lower (more...)
April 12, 2016 9:16 AM
Horizon Pharma (HZNP) Affirms FY 2016 Net Sales Guidance
April 12, 2016 8:09 AM
Horizon Pharma (HZNP) Offers H116 Net Sales, adj.-EBITDA Outlook; Provides Q1 Prescription Results
April 12, 2016 8:07 AM
